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Abstract
Liver sinusoidal endothelial cells (LSEC) are characterized by the presence of
fenestrations that are not bridged by a diaphragm. The molecular mechanisms that
control the formation of the fenestrations are largely unclear. Here we report that
mice, which are deficient in plasmalemma vesicle-associated protein (PLVAP),
develop a distinct phenotype that is caused by the lack of sinusoidal fenestrations.
Fenestrations with a diaphragm were not observed in mouse LSEC at three weeks
of age, but were present during embryonic life starting from embryonic day 12.5.
PLVAP was expressed in LSEC of wild-type mice, but not in that of Plvap-deficient
littermates. Plvap-/- LSEC showed a pronounced and highly significant reduction in
the number of fenestrations, a finding, which was seen both by transmission and
scanning electron microscopy. The lack of fenestrations was associated with an
impaired passage of macromolecules such as FITC-dextran and quantum dot
nanoparticles from the sinusoidal lumen into Disse’s space. Plvap-deficient mice
suffered from a pronounced hyperlipoproteinemia as evidenced by milky plasma
and the presence of lipid granules that occluded kidney and liver capillaries. By
NMR spectroscopy of plasma, the nature of hyperlipoproteinemia was identified as
massive accumulation of chylomicron remnants. Plasma levels of low density
lipoproteins (LDL) were also significantly increased as were those of cholesterol
and triglycerides. In contrast, plasma levels of high density lipoproteins (HDL),
albumin and total protein were reduced. At around three weeks of life, Plvap-
deficient livers developed extensive multivesicular steatosis, steatohepatitis, and
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fibrosis. PLVAP is critically required for the formation of fenestrations in LSEC. Lack
of fenestrations caused by PLVAP deficiency substantially impairs the passage of
chylomicron remnants between liver sinusoids and hepatocytes, and finally leads to
liver damage.
Introduction
Endothelial cells of liver sinusoids differ from that of other capillaries because of
the presence of open fenestrations and the absence of a basal lamina [1–4]. The
diameter of the sinusoidal fenestrations varies between different species and
measures 107¡1.5 nm (mean ¡ SEM) in the human liver [5], while for the
mouse liver an average diameter of 141¡5.4 nm (mean ¡ SEM) [5] was
determined on tangentially sectioned transmission electron micrographs, a
method that largely avoids shrinkage effects [6]. A specific function of liver
sinusoids is the filtration of particles that are exchanged between the sinusoidal
lumen and the space of Disse, allowing only particles smaller than the fenestrae to
reach the hepatocytes or to leave the space of Disse [7]. Such a filter function
appears to be especially important for the passage of lipoproteins. In support of
this are observations of numerous chylomicron remnants with a size smaller than
the diameter of fenestrations in the space of Disse of breastfeeded rat pups [8].
Moreover, several studies found evidence for a negative correlation between
fenestration size and number, and the plasma concentration of larger lipoproteins
[1, 9]. Still, others did not find evidence supporting the assumption that the
diameter of liver sinusoidal fenestrae is a major determinant of plasma lipoprotein
levels [10].
The proliferation and survival of sinusoidal endothelial cells [11], as well as
their capability to form fenestrations [9], depend on vascular endothelial growth
factor (VEGF) that is secreted from hepatocytes [9]. Otherwise very little is known
about the signaling mechanisms that modulate the maintenance and turnover of
fenestrations in liver sinusoids. Multiple agents were shown to modulate size and
numbers of fenestrations [1]. Still, a specific molecule that is part of the biological
process behind pore formation in the wall of a sinusoidal endothelial cell in the
liver has not been identified.
Capillary endothelial cells of other organs with high demands for the passages
of fluids and solutes differ from sinusoidal endothelial cells of the liver as they
form fenestrae that are covered by a thin 5–6 nm non-membranous diaphragm
[3, 12]. The only protein that has been identified to be a component of endothelial
diaphragms is plasmalemma vesicle-associated protein (PLVAP, synonyms:
MECA32, PV-1), an endothelial-specific, cationic, integral membrane glycopro-
tein [13, 14]. We and others recently showed that PLVAP is critically required for
the formation of endothelial diaphragms which are completely absent in
endothelia of Plvap-deficient mice [15, 16].
PLVAP, Sinusoidal Pores and Lipoprotein Passage
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Here we report that the absence of PLVAP in Plvap-deficient mice causes a
pronounced reduction in the number of fenestrations in sinusoidal endothelial
cells of the liver. Our results indicate that PLVAP is not only required for the
formation of endothelial diaphragms, but also for the formation of endothelial
fenestrae, even of those without diaphragms. The lack of sinusoidal fenestrations
impairs the passage of macromolecules between the sinusoidal lumen and Disse’s
space. A direct result is the presence of a severe hyperlipoproteinemia caused by
the massive accumulation of chylomicron remnants in the plasma of Plvap-
deficient animals. The phenotype provides clear molecular evidence for the
assumption that open fenestrae in liver sinusoidal cells are critically required for
the passage of lipoproteins.
Materials and Methods
Animals
All procedures conformed to the tenets of the National Institutes of Health
Guidelines on the Care and Use of Animals in Research, the EU Directive 2010/63/
E, institutional guidelines and were approved by the local authority (Regierung
der Oberpfalz, Bavaria, Germany) and the Animal Care and Use Committee
(Tierschutzausschuss) of the University of Regensburg. Mice were housed under
standard laboratory conditions (12–12 h light-dark cycle, lights on at 6 am, 22 C˚,
and 60% humidity) with food and water ad libitum. Plvap-/- mice were used as
described previously [17]. Mice were kept in a mixed C57BL/6N/FVB-N
background. All experiments were performed in mice of either sex. Genotyping
was routinely performed by PCR analysis, using two upper primers located in
intron 1 of Plvap (59-AGAGCCTTCTCTGCCAAGTG-39) and in the inserted
cassette (59-TCTCATGCTGGACTTCTTCG-39) and a lower primer located in
intron 1 downstream of the cassette (59-GGCTAGCCTGAGCTACAGAGG-39)
resulting in a 672 bp PCR fragment for the wild-type allele and a 552 bp fragment
for the targeted allele. DNA was obtained from tail tips. PCR was performed in
15 ml reaction volumes containing standard buffer, 0.1 mM of each primer, 1 mM
dNTPs, 2.5 mM MgCl2, 8% glycerol, 0.2 mM cresol red sodium salt (Sigma,
Taufkirchen, Germany) and 0.25 U Taq polymerase (New England Biolabs,
Taufkirchen, Germany). The cycling conditions consisted of an initial 3 min
denaturing step at 94 C˚, followed by 34 cycles for 30 s at 94 C˚, for 1 min at 65 C˚,
and for 1 min 15 s at 72 C˚.
Western blot analysis
Fresh lung samples were homogenized in RIPA buffer (150 mM NaCl, 1% NP-40,
0.5% deoxycholic acid, 0.1% SDS, and 50 mM Tris), and insoluble constituents
were removed by centrifugation. For western blot analysis of PLVAP up to 30 mg
of protein were subjected to 10% SDS-PAGE and transferred onto a PVDF
membrane (Roche Diagnostics GmbH, Mannheim, Germany) by semidry
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blotting. After blocking with 5% BSA in TBS-T, membranes were incubated
overnight with rat anti-pan ECA (Meca32) IgG2a antibodies (Santa Cruz
Biotechnology, Santa Cruz, CA, USA), diluted 1:250 in 0.5% BSA in TBS-T. After
washing in TBS-T, membranes were hybridized with HRP-conjugated chicken
anti-rat antibodies (Santa Cruz), diluted 1:1000 in 0.5% BSA in TBS-T. For
visualization, membranes were incubated in Luminata Forte Western HRP
substrate (Millipore Corporation, Billerica, MA, USA) and visualized on a LAS
3000 Imager work station (Fujiifilm, Du¨sseldorf, Germany). As loading control,
membranes were incubated with HRP-conjugated rabbit anti-GAPDH antibodies
(Cell Signaling, Technologies, Beverly, MA), diluted 1:1000 in 0.5% BSA in TBS-
T.
RNA analysis
Total RNA from fresh lung and liver samples was extracted with peqGold Trifast
(Peqlab, Erlangen, Germany) according to manufacturer’s instructions. First-
strand cDNA from total RNA was generated using qScript cDNA synthesis kit
(Quanta BioScience Inc., Gaithersburg, MD, USA) according to the manufac-
turer’s recommendations. RNA that was not reverse transcribed into cDNA served
as negative control for real-time RT-PCR and RT-PCR. Primer pairs (Table 1)
were purchased from Invitrogen (Darmstadt, Germany) and were designed to
extend over exon–intron boundaries. Real-time RT-PCR was performed on a
BioRad iQ5 real-time RT-PCR detection system (BioRad) with the temperature
profile as follows: 40 cycles of 10 s melting at 95 C˚ and 40 s of annealing and
extension at 60 C˚. In initial experiments, the potential housekeeping genes for
real-time RT-PCR were identified for each tissue and best results were obtained
for GAPDH. Quantification was performed using BioRad iQ5 standard edition
(version 2.0.148.60623) software (BioRad). For RT-PCR, first strand cDNA was
generated using qScript cDNA synthesis kit (Quanta BioScience Inc.,
Gaithersburg, MD, USA) according to the manufacturer’s recommendations.
RNA that was not reverse transcribed into cDNA served as negative control. RT-
PCR was performed in 25 ml reaction volumes containing standard buffer, 0.1 mM
of each primer, 1 mM dNTPs, 2.5 mM MgCl2, and 0.25 U Taq polymerase (New
Table 1. Primers used for real-time RT-PCR and RT-PCR.
Real-time RT-PCR
mPlvap fwd 5’-TCAACAAGACCTGCGAAGC-3’
mPlvap rev 5’-AGCACACTGCCTTCTCCTTG-3’
mGAPDH fwd 5’-TGTCCGTCGTGGATCTGAC-3’
mGAPDH rev 5’-CCTGCTTCACCACCTTCTTG-3’
RT-PCR
mPlvap fwd 5’-CTATCATCCTGAGCGAGAAGC-3’
mPlvap rev 5’-GCAGCAGGGTTGACTACAGG-3’
doi:10.1371/journal.pone.0115005.t001
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England Biolabs, Taufkirchen, Germany). The cycling conditions consisted of an
initial 3 min denaturing step at 94 C˚, followed by 37 cycles for 30 s at 94 C˚, for
50 s at 63 C˚, and for 90 s at 72 C˚.
Electron microscopy
For transmission electron microscopy of mouse livers, deeply anesthetized mice
(120 mg/kg body weight i.m. ketamine and 8 mg/kg body weight i.m. xylazine)
were either fixed by intracardial perfusion with 2.5% glutaraldehyde in 0.1 M
cacodylate buffer (pH 7.4) followed by immersion fixation in 2.5% glutaraldehyde
in 0.1 M cacodylate buffer (pH 7.4) overnight, or by immersion fixation alone.
Afterwards, livers were treated with 1% OsO4, 0.8% K4[Fe(CN)6] in 0.1 M
cacodylate buffer for 1.5 h, dehydrated with graded ethanol solutions and
embedded in Epon (Roth, Karlsruhe, Germany). Semi-thin sections were stained
with Richardson’s stain. Ultrathin sections were stained with uranyl acetate and
lead citrate, and analyzed on a transmission electron microscope (Libra, Zeiss).
For scanning electron microscopy of mouse livers, deeply anesthetized mice
(120 mg/kg body weight i.m. ketamine and 8 mg/kg of body weight i.m. xylazine)
were fixed by intracardial perfusion with 2.5% glutaraldehyde in 0.1 M cacodylate
buffer (pH 7.4). Liver samples were isolated and further fixed by immersion in
2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) overnight. After
treatment with 1% OsO4, 0.8% K4[Fe(CN)6] in 0.1 M cacodylate buffer for 1.5 h,
the samples were rinsed in four changes of 0.1 M cacodylate buffer and immersed
in 30% N,N-dimethylformamide (DMF) dissolved in 0.1 M cacodylate buffer for
30 min. The liver samples were frozen with liquid nitrogen and were crushed into
randomized pieces which were placed again in 30% DMF for 30 min, then rinsed
twice with buffer and three changes of distilled water. The specimens were
dehydrated in ascending acetone solutions and critical point dried using a CP
drying apparatus E 3000 (Quorum Technologies Ltd, East Sussex, United
Kingdom) with CO2 substitution. Dried samples were sputter-coated with
platinum and examined with a field-emission scanning electron microscope (LEO
1530, Zeiss).
Perfusion studies
For liver perfusion via the portal vein, mice were deeply anesthetized (120 mg/kg
of body weight i.m. ketamine and 8 mg/kg body weight i.m. xylazine). The
abdomen was opened and the portal vein was cannulated using a 27 gauge needle
(Henry Schein, Melville, NY, USA). The needle was attached via disposable
Mallinckrodt pressure tubing with an inner diameter of 0.050" and 24" length
(Tyco Healthcare, Pleasanton, CA, USA) to a 3-way-stopcock (Fresenius Kabi AG,
Bad Homburg, Germany). Two additional pressure tubes which are connected to
two 10 ml syringes (Henry Schein, Melville, NY, USA) were attached to the 3-way
stopcock. For perfusion, an infusion pump (PHD 2000, Harvard Apparatus,
Holliston, MA, USA) was used. Fluorescein isothiocyanate-dextran (FITC-
PLVAP, Sinusoidal Pores and Lipoprotein Passage
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dextran, FD70, Sigma, Taufkirchen, Germany) was dissolved at a concentration of
50 mg/ml in PBS. Qdot 655 ITK Amino (PEG) quantum dots (Life Technologies
GmbH, Darmstadt, Germany) were perfused at a total amount of 20 pmol for
each liver, with an infusion rate of 1 ml/min, and an infusion volume of 1 ml.
After start of the perfusion, the inferior vena cava was cut open. To fix the tissue
after perfusion, the 3-way-stopcock was switched to the syringe filled with 4%
PFA and perfusion was restarted with an infusion rate of 1 ml/min and an
infusion volume of 1 ml. Finally, right liver lobes were collected and further
processed for histology and immunohistochemistry.
Light microscopy
Embryos were obtained from timed matings with noon of the day of vaginal plug
discovery designated as 0.5 days of gestation (E0.5). Embryos and tissues were
collected and fixed by immersion in 4% PFA for 4 h. After fixation, embryos and
tissue samples were washed in 0.1 M phosphate buffer (pH7.4), processed
through several graded alcohol and xylenes, and embedded in paraffin. For frozen
sections, the embryos and tissues were equilibrated in 10, 20, and 30% sucrose for
4 h and embedded in Tissue Tek optimal cooling temperature (OCT) compound
(Sakura Finetek Europe B.V., Zoeterwoude, NL) and cooled at 220 C˚. After
removal of paraffin, the sections were stained with hematoxylin and eosin (H&E)
and analyzed using a Zeiss Axio Imager microscope (Carl Zeiss AG, Oberkochen,
Germany). For sirius red staining, de-waxed sections were stained with Weigert’s
hematoxylin (1% hematoxylin, pH 5.0–7.2 in 96% isopropyl alcohol) for 8 min
and then washed for 10 min in running tap water. Afterwards the sections were
stained with 0.1% picro-sirius in saturated aqueous solution (Waldeck GmbH &
Co., Division Chroma, Mu¨nster, Germany) for 1 h. After two washing steps in
acidified water (0.5% acetic acid diluted in distilled water), the water was
physically removed from the slides and the sections were dehydrated through
three steps of 100% ethanol for 10 min. Afterwards the sections were cleared in
two steps of 100% xylenes for 10 min, mounted with DePeX (Serva
Feinbiochemica, Heidelberg, Germany) and examined using a Zeiss Axio Imager
microscope. For staining for periodic acid-Schiff (PAS) de-waxed paraffin sections
were oxidized by 1% periodic acid dissolved in 70% ethanol for 10 min and
washed 3 times in distilled water for 1 min. Afterwards, the aldehyde groups were
detected by Schiff reagent and counterstained with Weigert’s hematoxylin.
Sections were processed through several graded alcohol and xylenes and mounted
with DePeX. For staining of b-galactosidase activity, embryos were fixed in 2%
glutaraldehyde in 5 mM EGTA (pH 7.3) and 2 mM MgCl2 dissolved in PBS for
4 h on ice with shaking. After three 30 min rinses in washing buffer (2 mM
MgCl2, 0.01% sodium deoxycholate, 0.02% Nonidet-P40 in PBS), b-galactosidase
activity was visualized in X-Gal staining solution (2 mM MgCl2, 0.01% sodium
deoxycholate, 0.02% Nonidet-P40, 5 mM potassium ferrocyanide, 5 mM
potassium ferricyanide, 1 mg/ml X-Gal in PBS). Tissues were stained for 24 h at
37 C˚ in the dark, washed three times for 5 min in washing buffer, and embedded
PLVAP, Sinusoidal Pores and Lipoprotein Passage
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in Tissue-Tek for frozen sections. P-phenylendiamine (PPD, Carl Roth, Karlsruhe,
Germany) staining was performed on semi-thin sections of liver and kidney.
Sections were stained with 1% PPD solution (10 mg/ml PPD in 98% ethanol) for
30 min at room temperature in the dark. Afterwards the sections were
differentiated with 100% ethanol and counterstained with methylene blue.
Immunohistochemistry
Tissue samples were fixed by immersion in 4% PFA or Carnoy’s fixative (60%
methanol, 30% chloroform and 10% acetic acid) for 4 h, washed in 0.1 M
phosphate buffer, and embedded in either paraffin or Tissue-Tek. For detection of
PLVAP, CD31, and a-smooth muscle-actin, sections were blocked with 1% BSA,
0.2% cold water fish gelatin (Aurion, Wageningen, Netherlands), and 0.1%
Triton-X (all in 0.1 M phosphate buffer) for 1 h at room temperature. After
blocking, the sections were incubated with rat monoclonal antibodies pan ECA
(clone MECA-32, IgG2a, 1:50, Santa Cruz) specific against PLVAP [18, 19], goat
anti-CD31/PECAM-1 IgG (1:20, R&D systems, Wiesbaden, Germany) or goat
anti-a-smooth muscle-actin IgG (a-SMA) (1:200; GeneTex, Irvine, CA, USA).
Donkey anti-rat IgG (1:2500) or donkey anti-goat IgG (1:2500) each conjugated
to Cy3 (Jackson ImmunoResearch), or rabbit anti-goat IgG (1:1000) conjugated
to Alexa Fluor 488 (Life Technologies GmbH, Darmstadt, Germany) were used as
secondary antibodies. For fibronectin staining, sections were blocked with 2%
BSA and 0.1 M Triton-X in 0.1 M phosphate buffer for 1 h. After blocking,
sections were incubated with rabbit anti-fibronectin (1:500, Dako, Hamburg,
Germany). Goat anti-rabbit IgG (1:1000) conjugated to Alexa 488 (Life
Technologies GmbH, Darmstadt, Germany) were used as secondary antibodies.
For IBA-1 staining sections were pretreated with 0.05 M ammonium chloride for
30 min and with 0.5% Triton-X for 5 min. Afterwards, sections were blocked with
1% BSA, 0.2% cold water fish gelatin (Aurion, Wageningen, Netherlands), and
0.1% Triton-X (all in 0.1 M phosphate buffer) for 1 h at room temperature. After
blocking, sections were incubated with rabbit anti IBA-1 (1:100, Wako, Neuss,
Germany). Goat anti-rabbit IgG (1:1000) conjugated to Alexa 488 (Life
Technologies GmbH, Darmstadt, Germany) were used as secondary antibodies.
Primary antibodies were always incubated overnight at 4 C˚ and secondary
antibodies were incubated for 1 h at room temperature in the dark. Slides were
mounted with a medium containing 4’,6-diamidino-2-phenylindole (DAPI,
Vectashield; Vector Laboratories, Burlington, CA, USA) and analyzed under a
fluorescence microscope (Zeiss, Axio Imager). For negative controls, primary
antibodies were omitted and the sections were incubated with secondary
antibodies only.
TUNEL staining
Apoptotic liver cells were detected by terminal deoxynucleotidyl transferase-
mediated dUTP nick end labeling using the Deadend Fluorometric TUNEL
PLVAP, Sinusoidal Pores and Lipoprotein Passage
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system (Promega, Mannheim, Germany). Tissues were fixed in 4% PFA for 4 h.
After removal of paraffin, TUNEL staining was performed according to the
manufacturer’s instructions. Slides were analyzed under a fluorescence micro-
scope (Zeiss, Axio Imager).
Plasma analysis
For collection of blood plasma for lipoprotein analysis, mice were euthanized with
isoflurane and rapidly killed by decapitation to collect trunk blood. Blood samples
were centrifuged at 4000 g for 15 min and plasma was stored at - 20 C˚.
Hematocrit was evaluated by collecting trunk blood which was separated by
standard laboratory methods using heparinized micro hematocrit tubes (Brand
GmbH, Wertheim, Germany). Serum aspartate transaminase (AST), alanine
transaminase (ALT), albumin, HDL, LDL and total protein levels were measured
applying standard clinical laboratory tests. Total cholesterol and total triglycerides
were measured by standard enzymatic tests performed on a Dimension Vista
System (Siemens Healthcare Diagnostics GmbH, Eschborn, Germany).
NMR spectroscopy
NMR spectra were recorded on Avance 800 and 600 NMR spectrometers (Bruker
Biospin Karlsruhe, Germany) operating at 800.2 and 600.0 MHz proton
resonance frequencies, respectively. Both spectrometers were equipped with a
cryoprobe for obtaining a higher sensitivity. Spectra were recorded from blood
plasma of individual mice at 310 K. If the sample volume was smaller than
500 mL, an appropriate amount of physiological extracellular buffer [20] was
added up to 500 mL. Quantification of the plasma lipoproteins was obtained from
NOESY-type 1D spectra [21] and a set of Oneshot [22] diffusion weighted 1H
NMR spectra. The concentrations of the different lipoprotein subclasses defined
by the hydrodynamic radii rH was calculated according to methods published
previously [23, 24]. Chemical shifts d and hydrodynamic radii rH were referenced
to the methyl signal of lactate used as internal standard. The chemical shift of
lactate was set to 1.365 ppm, since it is known that the usual reference compound
DSS interacts with the lipoproteins. The hydrodynamic radius of Tris-buffer was
experimentally determined as 0.307 nm in a separate set of experiments and used
for the calibration of the hydrodynamic radii of the triplet signal in the
lipoproteins. The obtained rH-values were associated with different types of
lipoproteins from the data published for human lipoprotein subclasses [23]. The
relative concentration changes of the different lipoproteins were calculated for 3
samples each of wild-type and Plvap-/- littermates.
Quantitative analysis
For quantitative analysis of the number of fenestrations in liver sinusoids, the total
number of fenestrations was counted along the endothelium comprising a total
PLVAP, Sinusoidal Pores and Lipoprotein Passage
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Fig. 1. PLVAP in the liver. A, b-galactosidase stained sections through the livers of a Plvap-/- animal and its
wild-type littermate at E15.5. Staining is seen in the sinusoidal endothelium of the Plvap-deficient embryo
(white arrows), but not in the wild-type. Staining in the liver is patchy and weaker than the homogenous
staining of capillaries in the small intestine (In, black arrows) or skin (Sk, arrowheads). Lower panels show
magnification of the staining in liver sinusoids (white arrows). B, Immunolabeling for PLVAP (red) shows
staining in the sinusoidal endothelium of a wild-type embryo at E16.5 (boxed areas in the left panel). Stronger
immunostaining for PLVAP is seen in capillaries of the small intestine (white arrow) and the pancreas (black
arrow). No staining is seen in the Plvap-deficient littermate (right panel). Middle panel shows magnification of
the boxed panel. C, Liver staining for PLVAP (red) at P11 shows positive immunoreactivity in wild-type
sinusoidal endothelium, but not in the Plvap-/- littermate. Nuclear DNA is labeled with DAPI (blue). D and E,
PLVAP, Sinusoidal Pores and Lipoprotein Passage
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length of 2.5 mm in both wild-type and Plvap-/- littermates. The number of
fenestrations per mm capillary length was determined and expressed as mean ¡
SEM. Statistical analysis was done by a two-tailed Student’s t-test and p values
#0.05 were considered to be statistically significant.
Results
The loss of PLVAP in sinusoidal endothelial cells is associated
with a lack of fenestrations
To analyze the expression of Plvap in the developing liver, we stained for b-
galactosidase to detect the expression of the reporter gene lacZ. At embryonic day
(E) 15.5, a time when fenestrations have been formed in the sinusoids of the
mouse liver, we detected a positive staining in the sinusoidal endothelial cells of
Plvap-deficient embryos (Fig. 1A). In contrast, staining was essentially absent in
wild-type littermates (Fig. 1A). The b-galactosidase staining in the liver sinusoidal
endothelium was patchy and considerably weaker than the more homogenous
staining in the capillaries of the immediately adjacent small intestine or skin
(Fig. 1A) which show strong Plvap expression [16]. Comparable results were
obtained when localization of PLVAP was investigated by immunohistochemistry.
At E16.5, liver sinusoidal cells of wild-type embryos showed a distinct
immunoreactivity for PLVAP, a finding that was not observed in Plvap-/- embryos
(Fig. 1B). The immunoreactivity was patchy and weaker than in the capillaries of
the adjacent small intestine or pancreas (Fig. 1B). The immunoreactivity for
PLVAP in the sinusoidal endothelial cells of wild-type animals at P11 was of
similar intensity than in embryos, but more homogenous (Fig. 1C). Again, no
immunoreactivity for PLVAP was observed in Plvap-/- littermates (Fig. 1C).
PLVAP is a component of the diaphragms covering endothelial fenestrae,
transendothelial channels, and caveolae [14, 25]. Since the formation of fenestrae
with diaphragms precedes that of open fenestrae during development of the
sinusoidal endothelium in rat embryos [26], we assumed that the PLVAP staining
in the mouse embryos was associated with the formation of diaphragmed
fenestrae. Indeed, we observed fenestrae with a diaphragm in the sinusoidal
endothelium of mouse embryos starting from E12.5 (Fig. 1D). As expected,
fenestrae of sinusoidal endothelial cells in three-week-old mice were open while
fenestrae or transendothelial channels covered by diaphragms were not observed.
Also caveolae, which were only rarely observed in sinusoidal endothelial cells of
wild-type pups after birth, did not form stomatal diaphragms (Fig 1E), a finding
that corroborated results from a previous report [27]. Overall, our data did not
support the concept that the presence of PLVAP in sinusoidal endothelial cells of
TEM. Fenestrations bridged by 5 - 7 nm thick diaphragms (black arrows) are seen in wild-type sinusoidal
endothelium at E12.5 (D). Caveolae of wild-type sinusoidal endothelium at P20 are not bridged by stomatal
diaphragms (black arrow, E).
doi:10.1371/journal.pone.0115005.g001
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the postnatal mouse liver is associated with the presence of endothelial
diaphragms.
To analyze the expression of Plvap mRNA, we performed RT-PCR to amplify a
fragment at the predicted size of 901 bp from RNA of wild-type lung and liver,
but not in that from Plvap-deficient tissues (Fig 2A). When the expression of
Plvap was analyzed by quantitative real-time RT-PCR in RNA from wild-type
tissue at P17 to P18, we observed a 11.5-fold higher mRNA expression level in the
lung compared to the liver (Fig 2B), a finding that was consistent with the
reported high Plvap expression in the lung [13], and the weak Plvap promoter
activity in mouse liver as assessed by b-galactosidase staining in our study.
Western blot analysis with proteins isolated from lungs of wild-type, Plvap+/- and
Plvap-/- animals at P25 confirmed the specificity of the monoclonal antibodies
used to detect PLVAP (Fig 2C).
We next analyzed whether sinusoidal endothelial cells of Plvap-deficient mice
show ultrastructural changes when compared to wild-type littermates. By TEM,
Fig. 2. Plvap expression in the liver. A, RT-PCR analysis from lung and liver tissues. A 901 bp fragment
illustrates the mRNA expression of Plvap in the liver (+). cDNA from lung tissues served as positive control.
RNA that was not reverse transcribed into cDNA (2) and a non-template reaction served as negative controls.
No specific band was amplified from cDNA of Plvap-/- lung and liver. B, Real-time RT-PCR for Plvap with RNA
from wild-type liver (n54) and lung (n53) at P17 to P18. GAPDH was used as a reference gene. C, Western
blot analysis for PLVAP in proteins isolated from lungs of wild-type, Plvap+/- and Plvap-/- animals at P25.
doi:10.1371/journal.pone.0115005.g002
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numerous fenestrae were observed in sinusoidal endothelial cells of wild-type
animals at three weeks of age (Fig. 3A). In contrast, fenestrae were only very rarely
observed in the sinusoidal endothelium of Plvap-deficient littermates (Fig. 3A).
Moreover, in Plvap-/- mice the space of Disse was compressed and filled with fine
Fig. 3. Ultrastructure of Plvap-deficient sinusoids. A, TEM of a 3-week-old wild-type animal shows
numerous fenestrations in sinusoidal endothelial cells (black arrows). In contrast, fenestrations are very rare in
the Plvap-/- littermate (black arrow). Lower panels show magnification. While in the wild-type animal Disse’s
space (Di) is open, it is compressed and filled with fine granular electron-dense material in the Plvap-deficient
littermate (white arrows). He, hepatocyte, Lu, sinusoidal lumen. B, SEM of a 3-week-old wild-type animal
shows the arrangement of fenestrations (arrows) in sieve plates. In contrast, sinusoidal endothelial cells of a
Plvap-deficient littermate show only few fenestrations (arrows) which form individual openings. C, Quantitative
analysis of fenestrations per mm endothelial length in sinusoids of wild-type and Plvap-/- animals. N55, mean
¡ SEM, ***p50.00069.
doi:10.1371/journal.pone.0115005.g003
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granular electron-dense material which was observed adjacent to the hepatocyte
microvilli and which was not present in wild-type littermates (Fig. 3A). SEM
analyses confirmed the lack of fenestrae in sinusoidal endothelial cells of Plvap-
deficient mice. Accordingly, sinusoidal endothelial cells in wild-type mice
displayed numerous fenestrae that were arranged in sieve plates (Fig. 3B). In
contrast, sinusoidal endothelial cells of Plvap-deficient mice showed only very few
fenestrations which were not arranged in clusters, but rather formed individual
openings instead (Fig 3B). The diminished porosity of the sinusoidal endothelium
was verified by a quantitative analysis of the number of fenestrations and a highly
significant (p#0.001) and approximately 6.2-fold reduction in the number of
fenestrae was observed in Plvap-deficient mice (Fig. 3C).
The lack of fenestrations leads to a decrease in the permeability of
sinusoidal endothelial cells
We next analyzed if the absence of PLVAP and the decrease in the number of
fenestrations in sinusoidal endothelial cells was associated with major changes in
sinusoidal architecture. To this end we labeled the vascular endothelial cells of the
liver with antibodies against CD31 and detected no obvious differences between
Plvap-/- mice and wild-type littermates with regards to orientation and density of
positively labeled vascular endothelial cells (Fig. 4A). No obvious structural
differences in the architecture of liver sinusoids were observed when semi-thin
sections were studied (Fig. 4B). A distinct difference though between the
sinusoids of Plvap-deficient mice and that of wild-type littermates was the higher
number of mononuclear cells (presumably Kupffer cells) in the lumen of the
Plvap-/- sinusoids (Fig. 4B). In addition, livers of Plvap-/- mice showed areas with
accumulations of mononuclear cells in Disse’s space (Fig. 4B). We next tested the
permeability of the sinusoids for macromolecules by perfusion with 70 KDa
FITC-dextran possessing a hydrodynamic diameter of approx. 10 nm via the
portal vein. After perfusion of wild-type animals, a strong FITC-signal was
detected throughout the entire liver. Immunolabeling with CD31 strongly
suggested that numerous FITC-dextran molecules had passed the endothelial cells
via their fenestrae and had accumulated in the space of Disse (Fig. 4C). In
contrast, in Plvap-deficient littermates a signal for FITC-dextran was barely
detectable (Fig. 4C). In a parallel approach, we used 25 nm diameter quantum
dots [28] holding a CdSe-containing core for portal vein perfusion. The core
allowed us to measure the amount of cadmium per kg liver tissue by inductively
coupled plasma mass spectrometry (ICP-MS), which correlates with the amount
of quantum dots in the tissue after perfusion. Only 0.05 mg/kg cadmium was
detected in the liver homogenate from a Plvap-deficient mouse while the liver of
the wild-type littermate contained 1.2 mg/kg cadmium. Overall, our experiments
strongly supported the assumption of a constrained passage of macromolecules
and nanoparticles through the hepatic sinusoidal endothelium of Plvap-deficient
mice.
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Lack of sinusoidal fenestrae in Plvap-deficient mice causes
hyperlipoproteinemia and steatosis
We next hypothesized that the loss of sinusoidal fenestrations in Plvap-/- mice
should impair the passage of chylomicron remnants to hepatocytes, and analyzed
the animals for signs of hyperlipoproteinemia. Plasma isolated from 10-day-old
breastfeeding Plvap-deficient pups was whitish, milky and thus strongly indicative
of hyperlipoproteinemia (Fig. 5A). In contrast, plasma from wild-type littermates
Fig. 4. Diminished permeability of liver sinusoids in Plvap-deficient mice. Neither by
immunohistochemistry with antibodies against CD31 (A) nor by light microscopy of 1 mm semi-thin sections
(B, Richardson’s stain) obvious differences are detected with regards to the overall orientation and the density
of liver sinusoids between 3-week-old Plvap-/- mice and wild-type littermates. Sinusoids of Plvap-deficient
mice show a higher number of macrophages in their lumen (white arrows) and focal areas with accumulations
of mononuclear cells in Disse’s space (black arrows). Lower panels in B show higher magnifications. C, After
perfusion of a wild-type animal with FITC-dextran, a strong FITC-signal (green) throughout the liver is
detected. Immunolabeling with CD31 (red) suggests that FITC-dextran molecules have accumulated in the
space of Disse. In contrast, in the Plvap-deficient littermate, the signal for FITC-dextran is much weaker and
barely detectable. Nuclear DNA is labeled with DAPI (blue).
doi:10.1371/journal.pone.0115005.g004
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appeared clear. Upon macroscopic analysis, the blood in the vessels supplying the
small intestine or the kidneys had a milky color, while that of wild-type animals
was red (Fig. 5B). In contrast to the kidneys of wild-type animals, which had an
intense reddish color, those of Plvap-deficient littermates were pale (Fig. 5B). A
similar difference in color was observed upon macroscopic analysis of the livers
(Fig. 5B). The differences in color were not caused by anemia, as no obvious
differences in hematocrit readings were observed between Plvap-/- pups and their
wild-type littermates (Fig. 5A).
To clarify, if the differences in kidney or liver colors were caused by
hyperlipoproteinemia, we analyzed semi-thin sections of mice at three weeks of
Fig. 5. Hyperlipoproteinemia in Plvap-deficient mice. A, Plasma of a P10 Plvap-deficient pup looks milky
(arrows), while that from a wild-type littermate is clear. No obvious differences in hematocrit readings are
observed between a Plvap-/- pup and its wild-type littermate (right-handed panel). B, The blood in the
mesenterial or kidney vessels of a 3-week-old Plvap-deficient animal is milky (white arrows), while that of wild-
type animals is red. Boxed area displays a magnification of mesenteric capillaries that are cut open to show
milky blood (black arrow). Kidneys and livers of wild-type animals are of reddish color (black arrows), while
those of Plvap-deficient littermates are pale.
doi:10.1371/journal.pone.0115005.g005
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Fig. 6. Lipoproteins in capillaries and hepatocytes of Plvap-deficient animals. A, PPD-labeled granular
structures fill the lumen of kidney capillaries in a 3-week-old Plvap-/- mouse (arrows, boxed area, counterstain:
Richardson’s stain), while only erythrocytes are seen in the wild-type littermate (arrow, boxed area). B, The
granular structures (black arrows) in the lumen of Plvap-deficient capillaries have diameters between 50 to
500 nm and are homogenously electron-dense. The particles are surrounded by extracellular fibrils with the
ultrastructural characteristics of fibrin (white arrow) (TEM, lower panel shows higher magnification). C, PPD-
labeled granular structures are seen in the lumen of liver sinusoids in a Plvap-/- mouse but not in a wild-type
littermate (white arrows). The cytoplasm of the vast majority of Plvap-/- hepatocytes is densely filled with PPD-
labeled granules (black arrows) which are rare in hepatocytes of wild-type littermates (black arrows). D, By
TEM, numerous liposomes (black arrows) are seen in the Plvap-deficient liver indicating a pronounced
microvascular steatosis. Hepatocytes of the wild-type animal contain large aggregates of glycogen
(asterisks), which are absent in hepatocytes of the Plvap-deficient littermates. The lumen of Plvap-/- liver
sinusoids is occluded by fibrillar fibrin (white arrows) suggestive of thrombus formation.
doi:10.1371/journal.pone.0115005.g006
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age, which is close to the maximal life span of our strain of Plvap-deficient
animals. When kidney sections of Plvap-/- mice were labeled with the lipid stain
PPD, abundant granular structures were identified that filled the peritubular and
glomerular capillaries (Fig. 6A). In contrast, in kidneys of wild-type littermates
only erythrocytes were seen in the capillary lumen (Fig. 6A). By TEM, the
granular structures in the lumen of Plvap-deficient capillaries were identified as
homogenously electron-dense particles with diameters between 50 to 500 nm
(Fig. 6B). The particles were surrounded by extracellular fibrils with the
ultrastructural characteristics of fibrin indicating thrombus formation. When
semi-thin sections through the livers of Plvap-deficient animals were stained,
PPD-labeled granular structures were identified in the lumen of liver sinusoids
and in Kupffer cells (Fig. 6C). The cytoplasm of the vast majority of hepatocytes
was densely filled with PPD-labeled granules (Fig. 6C). Similar granules were only
occasionally observed in hepatocytes in wild-type littermates (Fig. 6C). By TEM,
the cytoplasmic granules were identified as liposomes indicating a pronounced
microvesicular steatosis of Plvap-deficient livers (Fig. 6D). Hepatocytes of wild-
type animals contained large aggregates of glycogen, which were absent in Plvap-
deficient littermates (Fig. 6D). Similar to the findings in kidney capillaries, the
lumen of liver sinusoids in Plvap-/- animals was frequently occluded by aggregates
of fibrillar fibrin suggestive of thrombus formation (Fig. 6D).
Increase in plasma chylomicron remnants in Plvap-deficient mice
To obtain molecular information on the nature of the particles that caused
hyperlipoproteinemia in Plvap-deficient mice, we performed pulsed gradient
stimulated echo NMR experiments and analyzed lipoprotein size and concen-
tration changes between wild-type and Plvap-deficient mice (Fig. 7). The data
were evaluated analogously to a well-established method for analysis of human
lipoproteins by NMR spectroscopy [23, 24]. For the analysis of the nature of the
respective lipoproteins, the nomenclature used for human lipoproteins, which are
defined by their hydrodynamic radii, was used [23, 24]. Peaks labeled with CH3
containing the signals of the methyl groups of fatty acids of complex lipids and
some cholesterol signals were analyzed. Evidently, the shape and intensity of the
peaks were different between wild-type and Plvap-/- mice (Fig. 7A). A triplet signal
for lipoproteins with a hydrodynamic radius of 80–100 nm (subclass 13) and
largely corresponding to the sizes of chylomicron remnants was increased
dramatically in Plvap-deficient mice (Fig. 7A, B). A much smaller increase was
observed for lipoproteins with sizes between 40 and 80 nm (subclasses 12, 11).
Within the limits of error, lipoproteins with sizes between 25 and 40 nm were
unchanged, but all smaller lipoproteins (subclasses 8-1) largely corresponding to
high-density lipoproteins (HDL) were almost completely abolished in Plvap-/-
mice. The relative concentration of large chylomicrons with diameters .150 nm
(subclass 15) was somewhat decreased in the plasma of Plvap-deficient mice.
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Steatosis in Plvap-deficient mice progresses to necrosis and
fibrosis
Since hepatic steatosis potentially progresses to severe liver disease, we analyzed
the livers of three-week-old Plvap-deficient mice and observed that the surface of
wild-type livers was smooth while that of Plvap-/- mice showed scar tissue
(Fig. 8A). By light microscopy of serially sectioned Plvap-/- livers at postnatal days
(P) 17 to 25, we detected in eight out of eight Plvap-/- livers that were investigated
varying degrees of liver damage. In contrast, damage was consistently absent in
livers of the respective wild-type littermates. Plvap-/- livers presented areas with
microvesicular and macrovesicular steatosis, hepatocyte ballooning, and infiltrates
of inflammatory cells (Fig. 8B). Moreover, we observed focal necrotic areas
(Fig. 8C) containing numerous TUNEL-positive nuclei (Fig. 8D).
Immunostaining for IBA-1 at P18 identified a pronounced increase in the number
of macrophages in Plvap-/- livers when compared to wild-type littermates
(Fig. 8E). By staining with sirius red, a fine positively-stained network was seen
around sinusoids (Fig. 8F, G). In addition, numerous intensely stained focal areas
(Fig. 8F) were detected as were areas with more diffuse staining (Fig. 8G), both
Fig. 7. NMR spectroscopy of wild-type and Plvap-deficient plasma. A, Part of 600 MHz 1H NMR spectra of wild-type and Plvap-/- mice at different
gradient strengths displaying the (CH3) signals from the methyl groups of the lipids of lipoproteins with maximum gradient strength of 0.535 T/m¡0.01 T/m
determined with a water reference sample, the different colors represent different gradient strengths. A strong decrease of the signal intensity corresponds to
a small hydrodynamic radius. B, Average difference (black bars) of the relative particle numbers DNrel in the lipoprotein subclasses L15 to L1
22 between
wild-type and Plvap-/- mice. The red bar indicates the signal intensity difference of the triplet signal visible in the Plvap-/- mice shown in A.
doi:10.1371/journal.pone.0115005.g007
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indicating a pronounced increase in the amounts of extracellular matrix. In
contrast, in wild-type littermates positive staining for sirius red was only seen
around larger hepatic vessels (Fig. 8F, G). Intense staining for PAS was seen in the
cytoplasm of wild-type hepatocytes (Fig. 8H) and correlated with the presence of
glycogen aggregates that were identified by TEM (Fig. 6D). Hepatocytes were not
reactive for PAS in livers of Plvap-/- littermates (Fig. 8H). In contrast, numerous
focal areas of positive extracellular PAS-labeling were observed (Fig. 8H). By
immunohistochemistry of P18 Plvap-/- livers, we regularly observed foci with
accumulations of a-smooth muscle actin-positive cells (Fig. 8I). In the liver, a-
smooth muscle actin is a specific marker for reactive hepatic stellate cells (HSC),
which are the cellular source of increased extracellular matrix (ECM) formation
and deposition in response to hepatic injury [29]. Similar areas showed an
increase in immunoreactivity for fibronectin (Fig. 8J). Focal areas that stained for
fibronectin or a-smooth muscle positive cells were essentially absent in the livers
of wild-type littermates (Fig. 8I, J). Together, these data indicate HSC reactivity
and enhanced fibrogenesis in P18 Plvap-/- livers. To assess functional liver
parameters, we performed clinical laboratory tests (Fig. 8K) and observed a
significant decrease in the amounts of total protein and albumin in the plasma of
Plvap-/- mice (n59) in comparison to that of wild-type littermates (n513)
(Fig. 8K). In addition, HDL was considerably decreased in plasma samples of
Plvap-/- mice (n59) compared to wild-type controls (n512) (Fig. 8K). In
contrast, the amounts of triglycerides (n59) and LDL (n59) were increased in the
plasma of Plvap-deficient animals when compared to that of their wild-type
littermates (n512 for LDL and n513 for triglycerides) (Fig. 8K). In addition,
cholesterol was increased more than 3-fold in the plasma of Plvap-/- mice
(380 mg/dl ¡119, n53) compared to the level of cholesterol in the wild-type
controls (103 mg/dl ¡30.7, n54; p,0.05) consistent with the accumulation of
relative cholesterol-rich chylomicron remnants. In some, but not all Plvap-/-
animals, the amounts of AST and ALT were increased (data not shown). When
urine of Plvap-/- animals and wild-type littermates was investigated by SDS-PAGE,
no signs of proteinuria were found (data not shown). Finally, we investigated
Disse’s space by TEM. Here, we regularly observed bundles of collagen fibrils with
the typical 67 nm periodicity of collagen types I or III in Plvap-deficient animals
Fig. 8. Liver fibrosis and necrosis in Plvap-deficient mice. A, The surface of a wild-type liver at three weeks of age is smooth while that of a Plvap-/-
mouse shows scars (white arrows). B, H&E stained paraffin section through the liver of a P17 Plvap-/- animal shows areas with microvesicular and
macrovesicular steatosis (white arrow), hepatocyte ballooning (black arrow), and infiltrates of inflammatory cells. C, H&E stained paraffin section through the
liver of a P18 Plvap-/- animal shows a focal necrotic area (white arrows). Similar areas are not seen in the wild-type littermate. D, Numerous TUNEL-positive
nuclei (white arrows) accumulate in a focal necrotic area of the P18 Plvap-/- animal shown in C. In contrast, only individual TUNEL-positive cells are rarely
seen in the wild-type littermate (black arrows). E, Immunostaining for IBA-1 (green) at P18 shows a higher number of macrophages (white arrows) in the
Plvap-/- liver when compared to the wild-type littermate. F, G, Sirius red staining in the liver of an P17 Plvap-/- mouse indicates focal fibrosis (F, white arrows)
and diffuse fibrosis around sinusoids (G, white arrows). In the wild-type littermate, positive staining for sirius red is only seen around larger hepatic vessels.
H, Intense staining for PAS is seen in the cytoplasm of wild-type hepatocytes. In contrast, hepatocytes are not reactive for PAS in the liver of a Plvap-/-
littermate with focal areas of positive extracellular PAS-labeling (black arrows). I, a-smooth muscle actin-positive cells accumulate in the liver parenchyma of
a Plvap-/- mouse (white arrows), but are only seen in the walls of blood vessels in the wild-type littermate. J, A similar area as in G shows immunoreactivity
for fibronectin in the liver of a Plvap-/- mouse (white arrows). Staining for fibronectin is essentially absent in the liver of the wild-type littermate. Nuclear DNA
is labeled with DAPI (blue). K. Plasma analysis of wild-type (n513) and Plvap-/- mice (n59) (mean ¡ SD).
doi:10.1371/journal.pone.0115005.g008
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at three weeks of age (Fig. 9). In contrast, no fibrillar extracellular matrix was seen
in Disse’s space of wild-type littermates (Fig. 9).
Discussion
We conclude that PLVAP is required for the formation of fenestrations in liver
sinusoidal endothelial cells. The reduced permeability impairs the passage of
chylomicron remnants and other lipoproteins such as LDL between the lumen of
liver sinusoids and hepatocytes, a scenario that causes hyperlipoproteinemia and
results in liver injury. The conclusions rest upon (1) the finding of a substantial
reduction in the number of fenestrations (2) the observation of impaired passage
of macromolecules and nanoparticles between sinusoids and Disse’s space (3) the
presence of a massive accumulation of plasma chylomicron remnants (4) the
increase in plasma LDL and the reduction in HDL, and finally (5) the
development of multivesicular steatosis, steatohepatitis, focal liver necrosis, and
fibrosis in Plvap-deficient animals.
Our data that show the expression of mRNA for Plvap in the mouse liver, albeit
at levels that are lower than in organs harboring capillaries with abundant
endothelial diaphragms, are essentially comparable to findings of others, which
detected Plvap mRNA in rat, mouse or human liver [13, 15, 30]. Moreover, similar
to our results in the mouse liver, immunoreactivity for PLVAP localizes
specifically to sinusoidal endothelial cells in the human liver [31], strongly
Fig. 9. Accumulation of collagen in livers of Plvap-deficient mice. By TEM of a Plvap-deficient animal at
three weeks of age, bundles of collagen fibrils with the typical 67 nm periodicity are seen in Disse’s space
(arrows). No fibrillar extracellular matrix is present in Disse’s space of the wild-type littermate. Lower panels
show higher magnification.
doi:10.1371/journal.pone.0115005.g009
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indicating that its function has been conserved throughout evolution. The
important role of PLVAP in transcellular pore formation appears not to be
restricted to the formation of fenestrations in the liver. When transcellular pores
are generated by vascular endothelial cells to allow leukocyte migration, PLVAP
forms a ring that surrounds the migrating lymphocytes and is supported by
vimentin filaments which physically interact with PLVAP [32]. Moreover,
blocking of PLVAP by antibodies resulted in a decrease in the number of
migrating leukocytes [32]. Studies on the mechanism of fenestration formation in
liver sinusoids identified cytoskeletal rings around the fenestrations [33, 34]. The
formation of fenestrations was significantly induced following experimental
disruption of the cortical actin fibers [33–35] and originated from a distinct focal
area that was termed ‘‘fenestrae-forming center’’ [33]. The entire process occurred
rapidly and likely required no de novo protein synthesis [33, 34]. It is tempting to
speculate that PLVAP molecules in or close to the plasma membrane are required
to facilitate local actin disruption and pore formation, processes that are
significantly less likely to occur in the absence of PLVAP. PLVAP is essential for
the formation of endothelial diaphragms [15, 16] and in recent studies we
observed a reduction in the number of diaphragmed fenestrations in the Plvap-/-
pancreas [16] or choroid of the eye [17]. In the liver, we found endothelial
diaphragms in wild-type embryonic sinusoids, but not after birth and regard it as
unlikely that the formation of an endothelial diaphragm by PLVAP is a
prerequisite for the formation of fenestrations in liver sinusoids. Data from in
vitro studies are consistent with this assumption [33, 34].
The accumulation of chylomicron remnants in the plasma of Plvap-/- mice
supports the concept that the structural characteristics of liver sinusoidal
endothelial cells, like the presence of open fenestrations and the absence of a basal
lamina, have developed in evolution to allow passage of lipoproteins that are small
enough in size [1, 36]. Dietary lipids are absorbed by enterocytes and packaged
into triglyceride-rich chylomicrons [37]. Chylomicrons have diameters between
75 nm and 1200 nm [23, 38] and cannot pass the endothelial wall of the
diaphragmed fenestrated capillaries in the intestine which allow passage of
particles with sizes between 6 and 12 nm [39]. Instead, chylomicrons enter the
lymphatic capillaries which have a discontinuous endothelial layer [40].
Chylomicrons reach the blood via the thoracic duct where most of their
triglycerides are rapidly removed by lipoprotein lipase (LPL), an enzyme localized
at the surfaces of capillaries in adipose and muscular tissues. Cholesterol-rich
chylomicron remnants are finally taken up in the liver, a process that requires
passage across the sinusoids and binding to both LDL receptor (LDLR) and LDL
receptor-related protein (LRP) on hepatocytes [41, 42]. Mice that are deficient in
LDLR and LRP show a comparable plasma increase in the amounts of
chylomicron remnants and total cholesterol as Plvap-/- mice [42].
It is tempting to speculate that the reduced number of fenestrations in Plvap-/-
mice hinders not only the passage of chylomicron remnants, but also that of
hepatocyte-derived lipoproteins towards the sinusoidal lumen. Our methods do
not allow to specifically assess the plasma amounts of very low density
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lipoproteins (VLDL), since the hydrodynamic radii of chylomicron remnants and
VLDL overlap, and chylomicron remnants trapped in the plasma are further
reduced in their diameters by the activity of LPL. Still, the increase in the plasma
amounts of LDL and the markedly reduced amounts of HDL indicate that lack of
fenestrations in sinusoidal endothelia does not only interfere with the passage of
lipoproteins from the sinusoidal lumen to Disse’s space, but also vice versa. VLDL
are assembled in hepatocytes and converted to LDL in the plasma, while HDL are
formed at the surface of hepatocytes [43, 44]. Liver-derived lipoproteins which are
not capable of passing the endothelial layer of Plvap-/- sinusoids would not
accumulate in Disse’s space, but be drained by the liver lymphatics to the
abdominal lymph nodes [45]. A reduced protein synthesis in Plvap-/- hepatocytes
compromised by steatosis and steatohepatitis will affect lipoprotein synthesis and
provides an alternative explanation for the reduced plasma amounts of HDL. In
support of this possibility are the reduced plasma amounts of total protein and
albumin in Plvap-/- animals. Finally, the loss of endothelial diaphragms in
capillaries outside the liver might be a contributing factor to hypoproteinemia and
the low plasma levels of small size lipoproteins such as HDL. The plasma proteins
might increasingly pass through fenestrations that are normally bridged by a
diaphragm, but are more permeable in Plvap-/- mice.
Stan and colleagues reported recently on the phenotype of Plvap-deficient mice
that were bred in a genetic background (hybrid intercrosses containing a mix of
Balb/c, C57Bl/6J and 129Sv/J) different from our animals [15]. The authors
observed similar plasma changes as reported here. Accordingly, Plvap-/- (Balb/c,
C57Bl/6J, 129Sv/J) mice showed a comparable increase in the plasma amounts of
larger lipoproteins and cholesterol, and a decrease in HDL, total protein and
albumin. The authors argued that the increase in larger lipoproteins might be a
sequel to hypoproteinemia, which may cause depletion of endothelial LPL in
animals [46]. We regard this possibility as unlikely, as our data clearly show a
specific increase in the amounts of chylomicron remnants, while the amounts of
chylomicrons were unchanged or decreased in the plasma of Plvap-/- mice. In
support of our assumption are data which show a correlation between
experimental loss of fenestrations and the impaired passage of small chylomicrons
in rat livers treated with poloxamer 407, a synthetic surfactant [47]. We suggest
that an analysis of the number of fenestrations and their permeability to
macromolecules in the sinusoids of Plvap-/- (Balb/c, C57Bl/6J, 129Sv/J) mice
might show changes comparable to that seen in our study.
For the synthesis of VLDL, hepatocytes require triglycerides, which derive from
chylomicron remnants, from de novo lipogenesis or from albumin-bound fatty
acids [48]. It seems reasonable to assume that the reduced availability of
chylomicron remnants stimulates Plvap-/- hepatocytes to increase fatty acid
synthesis from carbohydrates. Our observation of a decrease in the amounts of
hepatocyte glycogen supports this assumption. A chronic increase in lipogenesis is
a contributing factor for non-alcoholic fatty liver disease [49] and may well cause
or contribute to steatosis in Plvap-/- mice. The release of proinflammatory signals
from reactive Kupffer cells that ingested chylomicron remnants trapped in the
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sinusoidal lumen are likely to induce steatohepatitis. Consequently, hepatocytes of
Plvap-/- mice might die by apoptosis while reactive HSC transdifferentiate to
myofibroblasts, a key event in the pathogenesis of liver fibrosis [50, 51]. In general,
the number of sinusoidal fenestrations decreases significantly in liver fibrosis
[50, 52], a process that occurs in parallel with the formation of a continuous basal
lamina and has been termed ‘‘capillarization’’ [53]. Sinusoidal capillarization may
precede liver fibrosis, but it is unclear if it has the potential to initiate, directly or
indirectly, fibrosis [51, 54] Our results appear to answer this question since in
Plvap-/- mice the targeted null-mutation of an endothelial-specific molecule
primarily induces the lack of sinusoidal fenestrations and only secondarily,
directly or indirectly, leads to liver fibrosis.
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